HEL •
Healthcare •
Biotechnology •
Quote as of 05/12/2026 18:29
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeHEL
Market Capitalization42.58 mln
Float78.65 mln
Earnings Date05/19/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.11
Caution advised
Relative Strength
99
/ 100
Top performer
Debt / Equity
0.14
Very low leverage
ROE
-35.56
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Nanoform Finland Oyj helps pharmaceutical and biotech companies improve how drugs are made by breaking drug particles down to the nanoscale level. Founded in 2008 and based in Helsinki, the company offers a range of services including specialized particle engineering technologies, formulation development, and analytical support. It also provides STARMAP, a digital tool that helps clients identify which drug molecules are best suited for its nanoforming process.
